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CC BY-NC-ND license (http://creativBackground/purpose: Calcium hydroxide and mineral trioxide aggregate (MTA) are used for
inducing a calcific barrier at an open tooth root (apexification). The purpose of this study
was to compare the efficacy of calcium hydroxide and MTA for apexification of immature per-
manent teeth.
Methods: Medline, Cochrane, EMBASE, and Google Scholar were searched until November 24,
2015, using the keywords apexification, permanent teeth, MTA, and calcium hydroxide.
Results: Of 216 studies identified, four studies were included. There were no differences in the
clinical success rate [pooled odds ratio (OR)Z 3.03, 95% confidence interval (CI): 0.42e21.72,
p Z 0.271], radiographic success rate (pooled OR Z 4.30, 95% CI: 0.45e41.36, p Z 0.206), or
apical barrier formation rate (pooled OR Z 1.71, 95% CI: 0.59e4.96, p Z 0.322) between cal-
cium hydroxide and MTA groups. The time required for apical barrier formation was signifi-
cantly less in the MTA group (pooled difference in means Z 3.58, 95% CI: from 4.91 to
2.25, p < 0.001).
Conclusion: While both materials provide similar success rates, the shorter treatment time
with MTA may translate into higher overall success rates because of better patient compliance.
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Apical periodontitis can lead to pulpal necrosis and arrest
of root development, and is especially challenging to treat
in immature permanent teeth in children.1 Untimely or
incorrect management can result in loss of permanent
teeth, disorders of mandibular growth and masticatory
function, and even speech disorders and facial cosmetic
impairment.1,2 Thus, correct treatment to prevent any loss
of these teeth is vitally important. Apexification is a
nonsurgical method of inducing a calcific barrier at the
open root apex of nonvital teeth.1,2 The barrier prevents
toxins and bacteria from entering periradicular tissue, and
facilitates placement of a root canal sealant and filling
material.3 However, an ideal apexification material has yet
to be determined.
Calcium hydroxide is commonly used for apexification as
it has no adverse periapical reactions, predictable results,
and can be mixed with a number of different substances
(camphorated mono chlorophenol, distilled water, saline,
anesthetic solutions, chlorhexidine, and cresatin) to induce
apical closure.1,2 However, calcium hydroxide has a number
of limitations including variable treatment time ranging
from 5 months to 20 months, apical closure in relationship
to treatment time is unpredictable, an increased risk of
tooth fracture, and poor patient compliance with follow-up
due to the extended treatment time, all of which can affect
treatment outcomes.1,2
Mineral trioxide aggregate (MTA) is used as an apical
barrier for teeth with immature apices, repair of root
perforations, root-end filling, pulp capping, and pulpotomy
procedures.4 MTA has a number of favorable characteristics
including biocompatibility, antimicrobial activity and pre-
vention of bacterial leakage, no cytotoxicity, and can
stimulate cytokine release from bone cells to promote hard
tissue formation.5,6 It also has a shorter treatment time
compared with calcium hydroxide, and a more predictable
time to apical closure.5,6 However, MTA has some limita-
tions such as nonreinforcement of root canal dentin and a
higher cost than calcium hydroxide.5,6 In addition, there
are few studies examining the long-term efficacy of MTA for
endodontic treatment in primary teeth.4
Few high-quality studies have directly compared the
outcomes of calcium hydroxide and MTA for apexification,
and thus there is no consensus as to which may be associ-
ated with superior outcomes. Thus, the purpose of the
current study is to perform a meta-analysis comparing the
outcomes of calcium hydroxide and MTA for the apex-
ification of immature permanent teeth.
Methods
Strategy of literature search
PRISMA guidelines were used when conducting this sys-
tematic review and meta-analysis.7 Medline, Cochrane,
EMBASE, and Google Scholar were searched from inception
until November 24, 2015, using combinations of the key-
words apexification, permanent teeth, MTA, and calcium
hydroxide. Searches were performed by two independent
reviewers to identify potentially relevant articles, and thereference lists of potentially relevant articles were also
hand-searched. A third reviewer was consulted where there
was uncertainty regarding eligibility, and a decision arrived
at by consensus.
Study selection criteria and data extraction
Study inclusion criteria were: (1) randomized controlled
trials, prospective and retrospective studies, and case se-
ries; (2) patients had permanent immature teeth for which
apexification was indicated; (3) compared calcium hy-
droxide versus MTA; and (4) reported quantitative clinical
or radiographic outcomes. Letters, comments, editorials,
case reports, proceedings, and personal communications
were excluded. Studies that were performed in vitro and
those that did not report a quantitative primary outcome
were also excluded. The following information/data were
extracted from studies that met the inclusion criteria: the
name of the first author, year of publication, study design,
number of participants in each group, participants’ age and
sex, intervention, and clinical outcomes.
Quality assessment
The methodological quality of each study was assessed
using the risk-of-bias assessment tool outlined in the
Cochrane Handbook for Systematic Reviews of In-
terventions (version 5.1.0).8 Briefly, six domains are eval-
uated: (1) random sequence generation; (2) allocation
concealment; (3) blinding of patients and personnel; (4)
blinding of outcome assessment; (5) incomplete outcome
data; and (6) selective reporting risk. Risks of bias figures
were generated using Cochrane RevMan version 5.3 (The
Nordic Cochrane Centre, Copenhagen, Denmark).
Outcome measures and data analysis
The primary outcome was the clinical success rate. Sec-
ondary outcomes were radiographic success rate, apical
barrier formation rate, and the time required for apical
barrier formation.
Pooled odds ratios (ORs) were calculated for the
clinical success rate, radiographic success rate, and api-
cal barrier formation rate, and compared between the
calcium hydroxide and MTA groups. Differences in means
for the time required for apical barrier formation were
calculated and compared between the two groups. The
Cochran Q and the I2 statistic were used to assess het-
erogeneity among studies. A value of p < 0.10 of the Q
statistic was considered to indicate statistically significant
heterogeneity. The I2 statistic indicates the percentage of
the observed between-study variability due to heteroge-
neity rather than chance, and a value > 50% was
considered to indicate significant heterogeneity. If either
the Q statistic or I2 statistic indicated heterogeneity was
present, a random-effects model of analysis was used
(DerSimonianeLaird method). If no heterogeneity was
present, a fixed-effects model (ManteleHaenszel method)
was used. Sensitivity of the meta-analysis was assessed
using the leave-one-out approach. A two-sided p
value < 0.05 was considered to indicate statistical
Calcium hydroxide or MTA for apexification 525significance. If there were five or less studies, publication
bias was not assessed because more than five studies are
required to detect funnel plot asymmetry.9 All statistical
analyses were performed using the statistical software




A flow diagram of the study selection is shown in Figure 1.
A total of 216 studies were identified in the database
search, and 201 nonrelevant studies were excluded. The
full texts of 15 articles were examined for eligibility and 10
were excluded, the reasons for which are shown inFigure 1 Flow diagram oFigure 1. Thus, four studies were included in the meta-
analysis.10e13
A total of 80 teeth were included in the four studies, and
a summary of the characteristics and outcomes of the four
studies are shown in Table 1. The total number of teeth in
the MTA groups ranged from 10 to 15, the total number of
teeth in the calcium hydroxide group ranged from 10 to 15,
and the patient ages ranged from 6 years to 12 years. The
clinical success rate ranged from 93% to 100% in the MTA
groups, and from 87% to 100% in the calcium hydroxide
groups. The radiographic success rate was 100% in the MTA
groups and ranged from 87% to 93% in the calcium hydroxide
groups. The number of teeth with apical barrier formation
ranged from seven to 18 in the MTA groups, and from 10 to
13 in the calcium hydroxide groups, while the time required
for apical barrier formation ranged from 3.0 months tof the study selection.
Table 1 Basic characteristics of studies included in the meta-analysis.
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526 J.-C. Lin et al.4.5 months in the MTA groups and from 7.0 months to
7.9 months in the calcium hydroxide groups.
Clinical success rate
There was no significant heterogeneity when data from the
three studies reporting clinical success rate11e13 were
pooled (QZ 0.44, dfZ 2, pZ 0.801, I2Z 0%); therefore, a
fixed-effects model of analysis was used (Figure 2). The
analysis revealed that there was no statistical difference in
clinical success rate between the MTA group and calcium
hydroxide group (pooled OR Z 3.03, 95% CI: 0.42e21.72,
Z Z 1.10, p Z 0.271).
Radiographic success rate
Only two studies11,12 reported radiographic success rate
data. There was no significant heterogeneity when data
from the two studies were pooled (Q Z 0.06, df Z 1,
p Z 0.810, I2 Z 0%); therefore, a fixed-effects model of
analysis was used (Figure 3A). The analysis revealed there
was no statistical difference in the radiographic success
rate between the MTA group and the calcium hydroxideFigure 2 Forest plot for the meta-analysis of clinical success rategroup (pooled OR Z 4.30, 95% CI: 0.45e41.36, Z Z 1.26,
p Z 0.206).Apical barrier formation rate
All four studies provided apical barrier formation rate data
and were included in the analysis.10e13 There was no sig-
nificant heterogeneity when data from the four studies
were pooled (Q Z 4.70, df Z 3, p Z 0.195, I2 Z 36.20%);
therefore, a fixed-effects model of analysis was used
(Figure 3B). The analysis revealed there was no statistical
difference in the apical barrier formation rate between the
MTA group and the calcium hydroxide group (pooled
OR Z 1.71, 95% CI: 0.59e4.96, Z Z 0.99, p Z 0.322).
Time required for apical barrier formation
Two studies11,13 reported the time required for apical
barrier formation. There was no significant heterogeneity
when data from the two studies were pooled (Q Z 0.14,
df Z 1, p Z 0.711, I2 Z 0%); therefore, a fixed-effects
model of analysis was used (Figure 3C). The time required. CIZ confidence interval; MTAZ mineral trioxide aggregate.
Figure 3 Forest plots for the meta-analysis of: (A) radiographic success rate; (B) apical barrier formation rate; (C) time required
for apical barrier formation. CI Z confidence interval; MTA Z mineral trioxide aggregate.
Calcium hydroxide or MTA for apexification 527for apical barrier formation was significantly less in the MTA
group (pooled difference in means Z 3.58, 95% CI: from
4.91 to 2.25, Z Z 5.27, p < 0.001).Sensitivity analysis
The results of meta-analysis using the leave-one-out
approach to assess sensitivity are summarized in Figure 4.
The direction and magnitude of the pooled estimates of
clinical success rate did not vary considerably when indi-
vidual studies were removed in turn, indicating that the
meta-analysis had good reliability.Figure 4 Results of the sensitivity analysis to examine the influen
rate using the leave-one-out approach. CI Z confidence interval;Publication bias
Publication bias was not assessed for these outcomes
because more than five studies are required to detect
funnel plot asymmetry.Quality assessment
Results of the quality assessment of the studies are shown
in Figures 5A and 5B. Three of the four included studies had
low risk of bias in random sequence generation. All
included studies had low risk of bias in incomplete outcome
data and selective reporting. However, two of the fource of individual studies on pooled estimates for clinical success
MTA Z mineral trioxide aggregate.
Figure 5 Quality assessment results using the risk-of-bias assessment tool outlined in the Cochrane Handbook for Systematic
Reviews of Interventions (version 5.1.0): (A) risk of bias summary; and (B) overall assessment of risk of bias.
528 J.-C. Lin et al.studies had high risk of bias in blinding of participants and
personnel, and three studies had an unclear risk of bias in
intention-to-treat bias. Overall, the included studies had
low risk in attrition bias and reporting bias, but had high
risk in performance bias.Discussion
The purpose of this meta-analysis was to determine
whether calcium hydroxide or MTA provides betteroutcomes for the apexification of immature permanent
teeth, as no consensus has been reached with respect to
the use of these two materials and they both have unique
advantages and drawbacks. The results showed that both
materials had similar clinical success rates, radiographic
success rates, and apical barrier formation rates. However,
MTA was associated with a significantly shorter time to
achieve apical barrier formation than the calcium hydrox-
ide. This is of significance because many failures with cal-
cium hydroxide are due to poor patient follow-up because
of the extensive treatment time.
Calcium hydroxide or MTA for apexification 529Calcium hydroxide has long been considered the
method of choice for apexification, but its disadvantages
including a prolonged treatment time have resulted in
the search for new material.1,2 MTA is a mixture of
Portland cement and bismuth oxide that contains dical-
cium silicate, tricalcium silicate, tricalcium aluminate,
and tetracalcium aluminoferrite, as well as other mineral
oxides.14 The pH of 12.5 after setting is similar to that of
calcium hydroxide.14 MTA is unique in that it is the first
material that has been shown to consistently allow for
over growth of cementum and promote periodontal tissue
regeneration.6 While there are many animal studies that
have examined MTA, high quality human studies
comparing MTA and calcium hydroxide for apexification of
immature teeth are few.
Only one other systematic review has compared calcium
hydroxide and MTA for the apexificaiton of immature per-
manent teeth. In a meta-analysis published in 2011 by
Chala et al15 comparing calcium hydroxide and MTA, 300
studies of interest were identified but based on strict
criteria only two were included, and they were two studies
that were included in the current analysis.12,13 Based on
those two studies, the authors concluded that the results of
the two compounds were comparable. A 2010 review
compared the use of formocresol and MTA in primary teeth
pulpotomy, and considering the frequency of radiographic
findings such as furcation involvement and the potential
cytotoxicity of formocresol the authors concluded that MTA
was preferable.16
Individually, the four studies included in the current
meta-analysis support the use of MTA. El Meligy and Avery12
performed apexification with calcium hydroxide or MTA in
15 children with at least two necrotic permanent teeth and
performed clinical and radiographic evaluations at
3 months, 6 months, and 12 months after treatment.
Persistent periradicular inflammation and tenderness to
percussion was present at 6 months and 12 months in two of
15 teeth treated with calcium hydroxide and in none of the
teeth treated with MTA. Pradhan et al13 treated 20 nonvital
permanent maxillary incisors with unformed apices with
apexification with MTA or calcium hydroxide. The mean
time taken for apical biological barrier formation for the
MTA and calcium hydroxide groups were 3  2.9 months and
7  2.5 months, respectively, (p Z 0.008), and the total
treatment times for the two groups were
0.75  0.49 months and 7  2.5 months, respectively.
Damle et al11 treated 30 permanent incisors with necrotic
pulps and open apices with either MTA or calcium hydroxide
with follow-up at 12 months. The mean time to barrier
formation in the two groups was 4.50  1.56 months versus
7.93  2.53 months, respectively (p Z 0.0002) and the
mean time to radiographic evidence of completion of
lamina dura was 4.07  1.49 months versus
6.43  2.59 months, respectively (pZ 0.0067). In the most
recent study published in 2015, Bonte et al10 randomized
children with nonvital permanent incisors requiring apex-
ification to receive treatment with calcium hydroxide or
MTA. At 12 months, a mineralized barrier was observed in
50% of the children in the calcium hydroxide group and 82%
in the MTA group (p < 0.07). Importantly, four of 15 teeth in
the calcium hydroxide group developed root fractures
compared with none in the MTA group.Other studies that did not meet the inclusion criteria for
this analysis support the use of MTA. Lee at al17 divided 40
necrotic open-apex incisors in 40 children 6.5e10 years of
age into four treatment groups: Group 1, ultrasonic filing
and MTA placement; Group 2, ultrasonic filing and calcium
hydroxide; Group 3, hand filing and MTA; and Group 4, hand
filing and calcium hydroxide. Ultrasonic filing plus MTA had
the shortest time for apical hard tissue barrier formation,
whereas calcium hydroxide apexification was better than
MTA with respect to elongation of apical root length.
Qudeimat et al18 randomly assigned 64 permanent first
molars with carious pulp exposures in children to apex-
ification with calcium hydroxide or MTA. With an average
follow-up of 34.8  4.4 months there was no statistical
difference in the success rate of teeth treated with calcium
hydroxide (91%) or MTA (93%) and a radiographic hard tissue
barrier under calcium hydroxide was seen in 55% of teeth as
compared with 64% of teeth under MTA (p Z 0.4). Moretti
et al19 randomly assigned 45 primary mandibular molars
with dental caries in 23 children aged between 5 years and
9 years to receive calcium hydroxide, MTA, or control
treatment (zinc oxide-eugenol paste). With a follow-up
period of 24 months, clinical and radiographic success was
noted in all treated teeth in the control and MTA groups and
dentine bridge formation was detected in 29% of the teeth
treated with MTA. In teeth treated with calcium hydroxide,
64% of the teeth had clinical and radiographic failures
during the follow-up period, and internal resorption was a
frequent radiographic finding.
There are a number of limitations to this study. The
number of studies was small, and their quality was not high.
Results of apexification can be operator dependent. In
addition, the definitions of clinical and radiographic success
may have varied between the studies. We did not examine
the outcomes of the two compounds with respect to their
use for root fractures. These limitations suggest that future
high-quality studies are needed to compare the results of
the two treatments.
In summary, while both calcium hydroxide and MTA
provide similar clinical success and radiographic success
rates and apical barrier formation rates, MTA is associated
with a significantly shorter time for apical barrier forma-
tion, thus shortening the treatment time. The shorter
treatment time with MTA may translate into higher overall
success rates because of better patient compliance with
treatment completion.References
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